31 Mai 2011 06:30 AM Eastern Daylight Time ENZON Names Ana I. Stancic Chief Financial Officer PISCATAWAY, N.J.--(BUSINESS WIRE)--Enzon Pharmaceuticals, Inc. (Nasdaq: ENZN) today announced that Ana I. Stancic has been named Senior Vice President and Chief Financial Officer of the Company, effective June 8, 2011. ..... She currently serves as a member of the Board of Directors of Champions Oncology, Inc., KV Pharmaceutical and Genta Incorporated.
www.businesswire.com/news/home/20110531005047/en/...c-Chief-Financial
Zum einen kann es dann keine Luftnummer so sein, zum anderen werden dadurch auch neue Kontakte geknüpft. Vielleicht auch deswegen der große Umsatz letzte Woche.

